Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients (DAFNE Study)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 28 Jul 2017
At a glance
- Drugs Fidaxomicin (Primary)
- Indications Clostridium infections
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms DAFNE
- Sponsors Astellas Pharma
- 25 Jul 2017 Planned End Date changed from 1 Jun 2017 to 1 Jul 2017.
- 25 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 14 Sep 2016 Planned End Date changed from 1 Jun 2016 to 1 Jun 2017.